Literature DB >> 23805376

New Challenges in the Management of Diffuse Large B-Cell Lymphoma.

Christopher R Flowers, Loretta J Nastoupil, Leon Bernal-Mizrachi, Adam C Rose, Rajni Sinha.   

Abstract

Entities:  

Year:  2012        PMID： 23805376      PMCID： PMC3690658     

Source DB:  PubMed          Journal:  Treat Strategies Hematol        ISSN： 2047-7600


× No keyword cloud information.
  57 in total

1.  DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.

Authors:  Rita Shaknovich; Huimin Geng; Nathalie A Johnson; Lucas Tsikitas; Leandro Cerchietti; John M Greally; Randy D Gascoyne; Olivier Elemento; Ari Melnick
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

2.  Prognostic value of immunohistochemical classification of diffuse large B-cell lymphoma into germinal center B-cell and non-germinal center B-cell subtypes.

Authors:  Abeer A Saad; Nahla M Awed; Zeinab M Abdel-Hafeez; Gihan M Kamal; Hala M Elsallaly; Amal I Alloub
Journal:  Saudi Med J       Date:  2010-02       Impact factor: 1.484

3.  Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

Authors:  Heidi Nyman; Magdalena Adde; Marja-Liisa Karjalainen-Lindsberg; Minna Taskinen; Mattias Berglund; Rose-Marie Amini; Carl Blomqvist; Gunilla Enblad; Sirpa Leppä
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

4.  Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.

Authors:  Georg Lenz; R Eric Davis; Vu N Ngo; Lloyd Lam; Thaddeus C George; George W Wright; Sandeep S Dave; Hong Zhao; Weihong Xu; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Wing C Chan; Louis M Staudt
Journal:  Science       Date:  2008-03-06       Impact factor: 47.728

5.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

6.  Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

Authors:  P Feugier; A Van Hoof; C Sebban; P Solal-Celigny; R Bouabdallah; C Fermé; B Christian; E Lepage; H Tilly; F Morschhauser; P Gaulard; G Salles; A Bosly; C Gisselbrecht; F Reyes; B Coiffier
Journal:  J Clin Oncol       Date:  2005-05-02       Impact factor: 44.544

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.

Authors:  Luciano J Costa; Andrew L Feldman; Ivana N Micallef; David J Inwards; Patrick B Johnston; Luis F Porrata; Stephen M Ansell
Journal:  Br J Haematol       Date:  2008-05-15       Impact factor: 6.998

9.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

10.  Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Authors:  Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307
View more
  2 in total

1.  Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.

Authors:  Michelle J Lee; Jean L Koff; Jeffrey M Switchenko; C Ileen Jhaney; R Andrew Harkins; Sharvil P Patel; Sandeep S Dave; Christopher R Flowers
Journal:  Cancer       Date:  2020-05-29       Impact factor: 6.860

2.  Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.

Authors:  Amy A Ayers; Lin Lyu; Kaylin Dance; Kevin C Ward; Christopher R Flowers; Jean L Koff; Lauren E McCullough
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.